Retinoic acid syndrome: a case report.
Zhonghua Yi Xue Za Zhi (Taipei)
; 60(5): 273-6, 1997 Nov.
Article
em En
| MEDLINE
| ID: mdl-9509683
ABSTRACT
All-trans-retinoic acid (ATRA) is a differentiation agent which can induce complete remission in a majority of patients with acute promyelocytic leukemia (APL). Unfortunately, about one-fourth of patients thus treated may develop potentially fatal complications, including respiratory distress, fever, pericardial and pleural effusion, renal failure and hypotension which constitute the retinoic acid syndrome (RA syndrome). We report one APL patient, who presented with leukocytosis and subacute disseminated intravascular coagulopathy, and developed RA syndrome during treatment with ATRA.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tretinoína
/
Leucemia Promielocítica Aguda
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Zhonghua Yi Xue Za Zhi (Taipei)
Ano de publicação:
1997
Tipo de documento:
Article